BioSpace News Archive

The new Planmeca Romexis® 6.0 highlights usability and streamlines workflows

Planmeca is proud to announce a renewed version of its groundbreaking all-in-one software, Planmeca Romexis®.

March 12, 2019
·
2 min read
Planmeca Romexis® Dental PACS combines treatment planning and archiving of all images – also 3rd party data – in one database

Planmeca is pleased to introduce Planmeca Romexis® Dental PACS, the first software platform to allow image archiving, viewing and treatment planning in a single software.

March 12, 2019
·
2 min read
FDA

Sonavex Receives FDA 510(k) Clearance for EchoSure

Medical device company receives second FDA clearance, adding blood flow monitoring technology to portfolio

March 12, 2019
·
2 min read
Drug Development

FDA Green-Lights Two Therapies, While Late-Stage Successes Set Stage for Potential Approvals

The U.S. Food and Drug Administration has been busy approving new treatments for various diseases. Two days into the new week and the regulatory agency has green lit two therapeutics, while other companies are planning to file for potential approval.

March 12, 2019
·
4 min read
·
Alex Keown
Time Is of the Essence: 9 Ways to Overcome Chronic Lateness at Work

Do you struggle to make to work or meetings on time? If so, you’re not alone. Some studies have shown that 1 in 5 people are chronically late to work at least once a week, while others claim nearly 30% of all Americans are late to work every single day.

March 12, 2019
·
4 min read
·
Editorial Staff
Policy

FDA Warning Letters: An Overview of 2019’s Letters So Far

The FDA issues Warning Letters to biopharma, medical device and food companies when they find that a manufacturer has significantly violated FDA regulations. As of March 4, the agency issued 45 Warning Letters this year.

March 12, 2019
·
5 min read
·
Mark Terry
PULS changes its name to AQILION AB

The company Partners för Utvecklingsinvesteringar inom Life Science, P.U.L.S. AB is changing its name to AQILION AB.

March 12, 2019
·
2 min read
Drug Development

Sterna Biologicals Holds Scientific Advisory Board Meetings To Advance Phase Iib Clinical Development Program Of Sb010 In Asthma

Sterna biologicals GmbH & Co. KG announced that the company held two Scientific Advisory Board (SAB) meetings to evaluate the phase IIb clinical development program for SB010 in asthma.

March 12, 2019
·
4 min read
Biotech Beach

BIO-Europe Spring® 2019 comes to Vienna in two weeks for 13th annual springtime biopharma conference

On March 25–27, the thirteenth annual BIO-Europe Spring® international partnering conference will convene in Vienna, Austria, at the Messe Wien Exhibition and Congress Center.

March 12, 2019
·
3 min read
Business

Minoryx Therapeutics appoints Didier Le Normand as Group Chief Financial Officer (CFO) and General Manager of its Belgian subsidiary

Minoryx Therapeutics, a company specializing in the development of new drugs for orphan diseases, announces that it has appointed Didier Le Normand as Group CFO as well as General Manager of its recently opened Belgian subsidiary.

March 12, 2019
·
3 min read